MicroRNA市場-規模、シェア、動向分析レポート、予測2023-2030

レポートナンバー　0000035482

バイオ・ゲノム・再生医療

MicroRNA市場-規模、シェア、動向分析レポート、予測2023-2030

Grand View Research Inc.

MicroRNA Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023 - 2030

発刊日 2023/06

言語英語

体裁PDF/150ページ

ライセンス/価格150ページ

0000035482

Individual	5,950USD
Team	6,950USD
Enterprise	8,950USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

microRNA市場の規模、シェア、動向分析レポート：製品＆サービス別（プロファイリング、ローカリゼーション、定量化）、用途別（がん、神経疾患）、エンドユース別、地域別、およびセグメント予測、2023〜2030

レポートの概要
世界のマイクロRNA市場規模は2022年に14億3,000万ドルと評価され、2023年から2030年までに12.64%のCAGRで成長すると予想されています。市場の成長を促す要因には、バイオマーカーの理想的な候補として (microRNA) miRNA ツールの大部分が採用され、配列決定技術の技術的進歩と相まって、遺伝性疾患の発生率が増加していることが挙げられます。精密医療に対する需要の高まりと遺伝子に基づく疾患の発生率の増加により、miRNA に基づく診断と治療の進歩が推進されています。バイオテクノロジーにおけるCRISPRやNGSなどの画期的なイノベーションゲノミクスとヘルスケア分野の成長にプラスの影響を与えています。これらの革新により、miRNA 治療薬の臨床試験の数が加速しました。さらに、COVID-19のパンデミックにより、この疾患の遺伝子発現とワクチン開発のためのマイクロRNA研究が強化されました。たとえば、2020年4月に発表された研究では、SARS CoV-2 RNAゲノムに特異的なin vitroで構築されたmiRNAの使用がワクチンまたは治療法の開発に使用できることが示唆されました。マイクロRNAに関するこのような研究の増加は、市場にプラスの影響を与えました。

レポート詳細

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Outbreak of COVID - 19
3.3.2. Recent innovations in applications of miRNAs
3.3.2.1. Increased adoption for use as a biomarker
3.3.2.2. Therapeutic applications
3.3.3. High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
3.3.4. The success of miRNA in clinical trials
3.3.5. Technological advancements to support nucleic acid studies
3.3.6. Exponentially declining cost of sequencing
3.4. Market Restraint Analysis
3.4.1. High cost associated with microRNA kits and other products
3.4.2. Challenges in handling RNA & in-house development of assays for microRNA detection
3.4.3. Poor reproducibility of research and specificity of products
3.4.4. Limited life science research infrastructure in emerging markets
3.5. Business Environment Analysis
3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.5.2. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis

Chapter 4. Product & Service Business Analysis
4.1. MicroRNA Market: Product & Service Movement Analysis
4.2. Products
4.2.1. Products Market, 2018 - 2030 (USD Million)
4.2.2. Instruments
4.2.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.2.2.1.1. Technology
4.2.2.1.1.1. Technology Market, 2018 - 2030 (USD Million)
4.2.2.1.1.2. Real-Time PCR
4.2.2.1.1.2.1. Real-Time PCR Market, 2018 - 2030 (USD Million)
4.2.2.1.1.3. Microarray
4.2.2.1.1.3.1. Microarray Market, 2018 - 2030 (USD Million)
4.2.2.1.1.4. NGS
4.2.2.1.1.4.1. NGS Market, 2018 - 2030 (USD Million)
4.2.2.1.1.5. Others
4.2.2.1.1.5.1. Others Market, 2018 - 2030 (USD Million)
4.2.2.1.2. Workflow
4.2.2.1.2.1. Workflow Market, 2018 - 2030 (USD Million)
4.2.2.1.2.2. Isolation & Purification
4.2.2.1.2.2.1. Isolation & Purification Market, 2018 - 2030 (USD Million)
4.2.2.1.2.3. miRNA cDNA Synthesis
4.2.2.1.2.3.1. miRNA cDNA Synthesis Market, 2018 - 2030 (USD Million)
4.2.2.1.2.4. Profiling, Localization, & Quantification
4.2.2.1.2.4.1. Profiling, Localization, & Quantification Market, 2018 - 2030 (USD Million)
4.2.2.1.2.5. Functional Analysis & Others
4.2.2.1.2.5.1. Functional Analysis & Others Market, 2018 - 2030 (USD Million)
4.2.2.1.2.6. Others
4.2.2.1.2.6.1. Others Market, 2018 - 2030 (USD Million)
4.2.3. Consumables
4.2.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.2.3.1.1. Specimen
4.2.3.1.1.1. Specimen Market, 2018 - 2030 (USD Million)
4.2.3.1.1.2. Whole Blood
4.2.3.1.1.2.1. Whole Blood Market, 2018 - 2030 (USD Million)
4.2.3.1.1.3. Serum
4.2.3.1.1.3.1. Serum Market, 2018 - 2030 (USD Million)
4.2.3.1.1.4. Plasma
4.2.3.1.1.4.1. Plasma Market, 2018 - 2030 (USD Million)
4.2.3.1.1.5. FFPE
4.2.3.1.1.5.1. FFPE Market, 2018 - 2030 (USD Million)
4.2.3.1.1.6. Fresh Frozen Tissue
4.2.3.1.1.6.1. Fresh Frozen Tissue Market, 2018 - 2030 (USD Million)
4.2.3.1.1.7. Others
4.2.3.1.1.7.1. Others Market, 2018 - 2030 (USD Million)
4.2.3.1.2. Workflow
4.2.3.1.2.1. Workflow Market, 2018 - 2030 (USD Million)
4.2.3.1.2.2. Isolation & Purification
4.2.3.1.2.2.1. Isolation & Purification Market, 2018 - 2030 (USD Million)
4.2.3.1.2.3. miRNA cDNA Synthesis
4.2.3.1.2.3.1. miRNA cDNA Synthesis Market, 2018 - 2030 (USD Million)
4.2.3.1.2.4. Profiling, Localization, & Quantification
4.2.3.1.2.4.1. Profiling, Localization, & Quantification Market, 2018 - 2030 (USD Million)
4.2.3.1.2.5. Functional Analysis
4.2.3.1.2.5.1. Functional Analysis Market, 2018 - 2030 (USD Million)
4.2.3.1.2.6. Others
4.2.3.1.2.6.1. Others Market, 2018 - 2030 (USD Million)
4.3. Services
4.3.1. Services Market, 2018 - 2030 (USD Million)
4.3.2. Service Type
4.3.2.1. Type Market, 2018 - 2030 (USD Million)
4.3.2.1.1. Isolation & Purification
4.3.2.1.1.1. Isolation & Purification Market, 2018 - 2030 (USD Million)
4.3.2.1.1.2. miRNA cDNA Synthesis
4.3.2.1.1.2.1. miRNA cDNA Synthesis Market, 2018 - 2030 (USD Million)
4.3.2.1.1.3. Profiling, Localization, & Quantification
4.3.2.1.1.3.1. Profiling, Localization, & Quantification Market, 2018 - 2030 (USD Million)
4.3.2.1.1.4. Functional Analysis
4.3.2.1.1.4.1. Functional Analysis Market, 2018 - 2030 (USD Million)
4.3.2.1.1.5. Others
4.3.2.1.1.5.1. Others Market, 2018 - 2030 (USD Million)
4.3.3. Specimen
4.3.3.1. Specimen Market, 2018 - 2030 (USD Million)
4.3.3.1.1. Whole Blood
4.3.3.1.1.1. Whole Blood Market, 2018 - 2030 (USD Million)
4.3.3.1.2. Serum
4.3.3.1.2.1. Serum Market, 2018 - 2030 (USD Million)
4.3.3.1.3. Plasma
4.3.3.1.3.1. Plasma Market, 2018 - 2030 (USD Million)
4.3.3.1.4. FFPE
4.3.3.1.4.1. FFPE Analysis Market, 2018 - 2030 (USD Million)
4.3.3.1.5. Fresh Frozen Tissue
4.3.3.1.5.1. Fresh Frozen Tissue Market, 2018 - 2030 (USD Million)
4.3.3.1.6. Others
4.3.3.1.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis
5.1. MicroRNA Market: Application Movement Analysis
5.2. Cancer
5.2.1. Cancer Market, 2018 - 2030 (USD Million)
5.3. Infectious Diseases
5.3.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
5.4. Immunological Disorder
5.4.1. Immunological Disorder Market, 2018 - 2030 (USD Million)
5.5. Cardiovascular Disease
5.5.1. Cardiovascular Disease Market, 2018 - 2030 (USD Million)
5.6. Neurological Disease
5.6.1. Neurological Disease Market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis
6.1. MicroRNA Market: End-Use Movement Analysis
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
6.3. Academic & Government Research Institutes
6.3.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
6.4. Other end-users
6.4.1. Other end-users Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis
7.1. MicroRNA Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America MicroRNA Market, 2018 - 2030 (USD Million)
7.2.2. The U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. MicroRNA Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada MicroRNA Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe MicroRNA Market, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany MicroRNA Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK MicroRNA Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France MicroRNA Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy MicroRNA Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain MicroRNA Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark MicroRNA Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden MicroRNA Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway MicroRNA Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific MicroRNA Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan MicroRNA Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China MicroRNA Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India MicroRNA Market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea MicroRNA Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia MicroRNA Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand MicroRNA Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America MicroRNA Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil MicroRNA Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico MicroRNA Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina MicroRNA Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA MicroRNA Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa MicroRNA Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia MicroRNA Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE MicroRNA Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait MicroRNA Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Profiles/Listing
8.3.1. Merck KGaA
8.3.1.1. Overview
8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. QIAGEN
8.3.2.1. Overview
8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Horizon Discovery Group Co.
8.3.3.1. Overview
8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Thermo Fisher Scientific, Inc.
8.3.4.1. Overview
8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Synlogic
8.3.5.1. Overview
8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. GeneCopoeia, Inc.
8.3.6.1. Overview
8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. New England Biolabs
8.3.7.1. Overview
8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Quantabio
8.3.8.1. Overview
8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. NanoString Technologies, Inc.
8.3.9.1. Overview
8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Takara Bio, Inc.
8.3.10.1. Overview
8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. LGC Limited
8.3.11.1. Overview
8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. BioGenex
8.3.12.1. Overview
8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. SeqMatic LLC
8.3.13.1. Overview
8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.13.3. Product Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. Miltenyi Biotec
8.3.14.1. Overview
8.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.14.3. Product Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. Sistemic Scotland Limited
8.3.15.1. Overview
8.3.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.15.3. Product Benchmarking
8.3.15.4. Strategic Initiatives
8.3.16. Biodynamics Laboratory, Inc.
8.3.16.1. Overview
8.3.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.16.3. Product Benchmarking
8.3.16.4. Strategic Initiatives
8.3.17. ORIGENE TECHNOLOGIES, INC.
8.3.17.1. Overview
8.3.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.17.3. Product Benchmarking
8.3.17.4. Strategic Initiatives
8.3.18. Norgen Biotek Corp.
8.3.18.1. Overview
8.3.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.18.3. Product Benchmarking
8.3.18.4. Strategic Initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 4 Global MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 5 Global MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 6 Global MicroRNA Market, by Region, 2018 - 2030 (USD Million)
Table 7 North America MicroRNA Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 9 North America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 10 North America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 11 U.S. MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 12 U.S. MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 13 U.S. MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 14 Canada MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 15 Canada MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 16 Canada MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 17 Europe MicroRNA Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 19 Europe MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 20 Europe MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 21 Germany MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 22 Germany MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 23 Germany MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 24 UK MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 25 UK MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 26 UK MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 27 France MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 28 France MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 29 France MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 30 Italy MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 31 Italy MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 32 Italy MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 33 Spain MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 34 Spain MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 35 Spain MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 36 Denmark MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 37 Denmark MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 38 Denmark MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 39 Norway MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 40 Norway MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 41 Norway MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 42 Sweden MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 43 Sweden MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 44 Sweden MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 45 Asia Pacific MicroRNA Market, by Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 47 Asia Pacific MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 48 Asia Pacific MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 49 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 50 China MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 51 China MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 52 China MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 53 Japan MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 54 Japan MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 55 Japan MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 56 India MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 57 India MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 58 India MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 59 South Korea MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 60 South Korea MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 61 South Korea MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 62 Australia MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 63 Australia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 64 Australia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 65 Thailand MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 66 Thailand MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 67 Thailand MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 68 Latin America MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 69 Latin America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 70 Latin America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 71 Brazil MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 72 Brazil MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 73 Brazil MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 74 Mexico MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 75 Mexico MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 76 Mexico MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 77 Argentina MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 78 Argentina MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 79 Argentina MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa MicroRNA Market, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 84 South Africa MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 85 South Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 86 South Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 90 UAE MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 91 UAE MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 92 UAE MicroRNA Market, End-user, 2018 - 2030 (USD Million)
Table 93 Kuwait MicroRNA Market, by Product & Services, 2018 - 2030 (USD Million)
Table 94 Kuwait MicroRNA Market, by Application, 2018 - 2030 (USD Million)
Table 95 Kuwait MicroRNA Market, End-user, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Mineral Supplements, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 15 Global MicroRNA Market: Product & Service Movement Analysis
Fig. 16 Global MicroRNA Market, for Products, 2018 - 2030 (USD Million)
Fig. 17 Global MicroRNA Market, for Instruments, 2018 - 2030 (USD Million)
Fig. 18 Global MicroRNA Market, for Technology, 2018 - 2030 (USD Million)
Fig. 19 Global MicroRNA Market, for Real-Time PCR, 2018 - 2030 (USD Million)
Fig. 20 Global MicroRNA Market, for Microarray, 2018 - 2030 (USD Million)
Fig. 21 Global MicroRNA Market, for NGS, 2018 - 2030 (USD Million)
Fig. 22 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 23 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
Fig. 24 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
Fig. 25 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
Fig. 26 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
Fig. 27 Global MicroRNA Market, for Functional Analysis & Others, 2018 - 2030 (USD Million)
Fig. 28 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 29 Global MicroRNA Market, for Consumables, 2018 - 2030 (USD Million)
Fig. 30 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
Fig. 31 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
Fig. 32 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
Fig. 33 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
Fig. 34 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
Fig. 35 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
Fig. 36 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 37 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
Fig. 38 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
Fig. 39 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
Fig. 40 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
Fig. 41 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
Fig. 42 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 43 Global MicroRNA Market, for Services, 2018 - 2030 (USD Million)
Fig. 44 Global MicroRNA Market, for Type, 2018 - 2030 (USD Million)
Fig. 45 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
Fig. 46 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
Fig. 47 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
Fig. 48 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
Fig. 49 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 50 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
Fig. 51 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
Fig. 52 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
Fig. 53 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
Fig. 54 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
Fig. 55 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
Fig. 56 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 57 Global MicroRNA Market: Application Movement Analysis
Fig. 58 Global MicroRNA Market, for Cancer, 2018 - 2030 (USD Million)
Fig. 59 Global MicroRNA Market, for Infectious Diseases, 2018 - 2030 (USD Million)
Fig. 60 Global MicroRNA Market, for Immunological Disorder, 2018 - 2030 (USD Million)
Fig. 61 Global MicroRNA Market, for Cardiovascular Disease, 2018 - 2030 (USD Million)
Fig. 62 Global MicroRNA Market, for Neurological Disease, 2018 - 2030 (USD Million)
Fig. 63 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
Fig. 64 Global MicroRNA Market: End-Use Movement Analysis
Fig. 65 Global MicroRNA Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 66 Global MicroRNA Market, for Academic & Government Research Institutes, 2018 - 2030 (USD Million)
Fig. 67 Global MicroRNA Market, for Other end-users, 2018 - 2030 (USD Million)
Fig. 68 Regional Marketplace: Key Takeaways
Fig. 69 Regional Outlook, 2022 & 2030
Fig. 70 Global MicroRNA Market: Region Movement Analysis
Fig. 71 North America MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 72 U.S. MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 73 Canada MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 74 Europe MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 75 Germany MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 76 UK MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 77 France MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 78 Italy MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 79 Spain MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 80 Denmark MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 81 Norway MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 82 Sweden MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 83 Asia Pacific MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 84 Japan MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 85 China MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 86 India MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 87 Thailand MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 88 Australia MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 89 South Korea MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 90 Latin America MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 91 Brazil MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 92 Mexico MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 93 Argentina MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 94 Middle East and Africa MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 95 South Africa MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 96 Saudi Arabia MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 97 UAE MicroRNA Market, 2018 - 2030 (USD Million)
Fig. 98 Kuwait MicroRNA Market, 2018 - 2030 (USD Million)

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000035482

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。